CytomX Therapeutics Inc

Research CytomX Therapeutics Inc (CTMX) on Bullrun: market cap USD 814.21M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCTMX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 814.21M
• Financial periodFY2025
• RevenueUSD 76.20M
• Revenue growth-44.8%
• Net income-USD 17.37M
• Free cash flow-USD 75.81M

Valuation Snapshot

latest market cap is USD 814.21M.

About CytomX Therapeutics Inc

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines;

Frequently asked questions

What is CytomX Therapeutics Inc's market cap?

CytomX Therapeutics Inc's market capitalization is USD 814.21M.

What does CytomX Therapeutics Inc do?

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment.